Chen YH, Li WF, Chen YH, Tsai MC, Kuo YH, Wang JH, Chen CH, Lu SN, Wang CC, Hung CH*. Survival outcomes of conversion curative therapy following atezolizumab-bevacizumab in advanced hepatocellular carcinoma. Cancer Immunol Immunother. 2026 Jul 13;75(10):246. (SCI) 晚期肝細胞癌患者經癌自禦合併癌思停治療後接受根治性治療存活預後
